Show simple item record

dc.contributor.authorMukherjee, S
dc.contributor.authorVirdee, P
dc.contributor.authorShaw, R
dc.contributor.authorBridgewater, J
dc.contributor.authorRadhakrishna, Ganesh
dc.contributor.authorFalk, S
dc.contributor.authorScott-Brown, M
dc.contributor.authorStrauss, VY
dc.contributor.authorBrooks, C
dc.contributor.authorGillmore, R
dc.contributor.authorPatel, N
dc.contributor.authorTranter, B
dc.contributor.authorParsons, P
dc.contributor.authorSebag-Montefiore, D
dc.contributor.authorHawkins, M
dc.contributor.authorCorrie, PG
dc.contributor.authorMaughan, TS
dc.date.accessioned2019-04-29T09:48:52Z
dc.date.available2019-04-29T09:48:52Z
dc.date.issued2018en
dc.identifier.citationMukherjee S, Virdee P, Shaw R, Bridgewater J, Radhakrishna G, Falk S, et al. 720P SCALOP-2: A multi-centre randomised trial of induction chemotherapy followed by capecitabine +/-nelfinavir with high or standard dose radiotherapy for locally advanced pancreatic cancer (LAPC): Results of stage 1 - the non-randomised dose-finding component. Annals of Oncology. 2018;29(suppl_8).en
dc.identifier.pmidNo PMIDen
dc.identifier.doi10.1093/annonc/mdy282.103en
dc.identifier.urihttp://hdl.handle.net/10541/621725
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdy282.103en
dc.titleSCALOP-2: A multi-centre randomised trial of induction chemotherapy followed by capecitabine plus /-nelfinavir with high or standard dose radiotherapy for locally advanced pancreatic cancer (LAPC): Results of stage 1-the non-randomised dose-finding componenten
dc.typeMeetings and Proceedingsen
dc.contributor.departmentOncology, Oxford Institute for Radiation Oncology, Oxford, UKen
dc.identifier.journalAnnals of Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record